CPAP, Nutrition & Exercise Against Sleep Apnea
TINE
Tailored Intervention on Nutrition and Exercise for Obstructive Sleep Apnea Patients Treated With CPAP
1 other identifier
interventional
120
2 countries
2
Brief Summary
This study evaluates the addition of a comprehensive lifestyle program including dietary management and exercise to continuous positive airway pressure (CPAP) therapy in overweighted adults with obstructive sleep apnea. Half of the participants will receive CPAP therapy while the other half will have diet consultations, nordic walking sessions and CPAP.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Aug 2019
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 14, 2019
CompletedFirst Posted
Study publicly available on registry
May 22, 2019
CompletedStudy Start
First participant enrolled
August 21, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2022
CompletedAugust 9, 2021
August 1, 2021
3.3 years
May 14, 2019
August 5, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Health-related quality of life: SF-36
Mean difference in the general health perception (GH) domain on the Medical Outcome Study Short Form (SF-36) between groups
12 weeks
Secondary Outcomes (41)
General quality of life: SF-36
12 and 24 weeks
Specific quality of life: Calgary Sleep Apnea Quality of Life Index (SAQLI)
12 and 24 weeks
Daytime excessive sleepiness
12 and 24 weeks
Subjective sleep quality
12 and 24 weeks
Mood
12 and 24 weeks
- +36 more secondary outcomes
Study Arms (2)
Tailored intervention
EXPERIMENTALIn this group, participants will receive a comprehensive lifestyle program in addition to CPAP therapy which will include a supervised exercise program, diet interventions and behavioural counselling during 12 weeks. Then, participants will follow a real-world maintenance program from weeks 12 to 24. It will include one telephone-based contact per month with the study coordinator. Participants will be encouraged to maintain their lifestyle modification during this phase.
Control
ACTIVE COMPARATORParticipant in this group will benefit from routine CPAP therapy management from week 0 to 24.
Interventions
* The exercise program consists of 2 x 1.5-hour supervised nordic walking sessions weekly during 12 weeks and 1-hour unsupervised moderate physical activity per week from week 4. * The diet intervention includes one face-to-face consultation with a dietician and one telephone-based contact monthly, i.e. 6 diet interventions for 12 weeks. * Behavioural changes techniques will be included in diet and exercise interventions.
This intervention will include tailored instruction on CPAP use and standard advices on physical activity and nutrition at CPAP initiation.
Eligibility Criteria
You may qualify if:
- Patients newly diagnosed for obstructive sleep apnea and requiring CPAP therapy
- BMI\>25and≤40kg/m2
- Low physical activity (\< 150 min of MVPA per week)
- IAH≥15
- Able to give informed consent as documented by signature
You may not qualify if:
- Patients already treated for OSA or another sleep disorder
- Required use of supplemental oxygen
- Active infection, malignancy or chronic inflammatory disorders
- More than moderate alcohol use of \> 14 drinks per week
- Severe depression defined by a BDI \> 30
- Surgery within the previous 3 months
- Known cardiac or pulmonary disease contraindicating exercise training
- Patient with a bariatric surgery project or already operated
- Pregnant or lactating women
- Onset of a severe cardiac disease contraindicating exercise training
- Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, peripheral functional limitation.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Raphael Heinzerlead
- Swiss Lung Associationcollaborator
- Ligue Pulmonaire Vaudoisecollaborator
Study Sites (2)
Centre Hospitalier Universitaire Saint-Etienne
Saint-Etienne, 42055, France
Centre Hospitalier Universitaire Vaudois
Lausanne, 1011, Switzerland
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Raphael Heinzer, MD, PhD
University Hospital of Lausanne, Switzerland
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Prof.
Study Record Dates
First Submitted
May 14, 2019
First Posted
May 22, 2019
Study Start
August 21, 2019
Primary Completion
December 1, 2022
Study Completion
December 1, 2022
Last Updated
August 9, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share